Empagliflozin maintains capillarization and improves cardiac function in a murine model of left ventricular pressure overload
Abstract Patients with type 2 diabetes treated with Sodium glucose transporter 2 (SGLT2) inhibitors show reduced mortality and hospitalization for heart failure (HF). SGLT2 inhibitors are considered to activate multiple cardioprotective pathways; however, underlying mechanisms are not fully describe...
Guardado en:
Autores principales: | Masaaki Nakao, Ippei Shimizu, Goro Katsuumi, Yohko Yoshida, Masayoshi Suda, Yuka Hayashi, Ryutaro Ikegami, Yung Ting Hsiao, Shujiro Okuda, Tomoyoshi Soga, Tohru Minamino |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d12309a66d7741a1b29740eef4e5bfd0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cardiac mitofusin-1 is reduced in non-responding patients with idiopathic dilated cardiomyopathy
por: Yung Ting Hsiao, et al.
Publicado: (2021) -
Reminiscent capillarity in subnanopores
por: Irena Deroche, et al.
Publicado: (2019) -
On the impact of capillarity for strength at the nanoscale
por: Nadiia Mameka, et al.
Publicado: (2017) -
Capillarity ion concentration polarization as spontaneous desalting mechanism
por: Sungmin Park, et al.
Publicado: (2016) -
Empagliflozin in type 1 diabetes
por: Mathieu C, et al.
Publicado: (2019)